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Syndromic Approach to Diagnostic Testing
• Reasons to utilize diagnostic testing
• Testing methods
• Interpreting results based on test characteristics
• Improving result interpretation potential 
What is the purpose of diagnostic testing?
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What is the purpose of diagnostic testing
• To gather specific information that closes the gap (amount of 
uncertainty) between pre-test clinical suspicion and post-test 
probability of disease 
• To inform next steps 
Clinicians need to know:
• Should I treat this animal?
• Probability of treatment success vs. cost of drug + labor
• Do I need to manage risk to herd based on this animal
• Do I need to inform owner of risk to humans based on this animal
• What is the potential benefit to animal and at-risk population of:
• Treatment/Therapy
• Vaccination
• Preventative
• Outbreak reaction 
• Change in management
• Change in preventative strategies 
Evidence Based Veterinary Medicine 
• Bayesian theorem -
• Pr (H | Data) = Pr (Data | H) * Pr (H) / Pr (Data)
• Provides the basis for obtaining an updated belief (‘posterior’) 
about an existing hypothesis (‘prior’) given new data (‘likelihood’)
• Existing hypothesis = differential diagnosis 
• New data = diagnostic test result 
• Updated belief = updated diagnosis or differential list
Evidence Based Veterinary Medicine 
• Define “pre-test clinical suspicion”  probability estimate
• Incorporate uncertainty if needed  probability range
• Select appropriate test
• Interpret results in light of pre-test probability and test 
characteristics  post-test probability
• Use information to decide on next action needed
Bayesian Thinking
• Veterinarians are intuitive followers of Bayesian thinking 
• Integrating results of serial procedures to update differential 
list based on clinical suspicion before and after each procedure 
until level of uncertainty is minimized 
Bayesian Thinking - Patient Assessment
• Signalment
• Clinical History
• Owner reported abnormalities
• Management risk factors
• Environmental risk factors
• Clinical Examination of patient
• Detailed Examination of operation and population (if 
possible)
• Ancillary/Diagnostic testing 
Bayesian Thinking 
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• 5 year old female Boer goat 
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• Signalment:
• 5 year old female Boer goat
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Bayesian Thinking
• Clinical History 
• Owner reports that she has been “off” and not eating well 
• She has crusts on her face
• Now is having problems breathing and won’t stand up (weak?)
• Doe recently purchased and transported several hundred miles 2 
weeks ago 
• She was inspected before purchase and was fine 8 weeks ago
• Other goats in barn are now developing similar crusts on their 
heads and ears
Bayesian Thinking
• Clinical Suspicions:
Bayesian Thinking
• Clinical Exam 
• Crusts are obstructing nasal airway
• Multifocal, small, scaly / scabby lesions 
predominantly around muzzle and ears, 
but also extending along dorsum and 
flank.
Bayesian Thinking
• Clinical Exam 
• Elevated respiratory rate and heart rate 
but no abnormal lung sounds 
• Pale mucous membranes
Bayesian Thinking
• Need more information (testing) but stop and summarize what is 
known
• Clinical Suspicions:
• Syndrome(s):
• Problems:
• Differentials:
• What do we need to know to be able to finalize patient action 
plan/treatment protocol? 
Bayesian Thinking
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• Crusty, proliferative skin lesions – Infectious? 
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Bayesian Thinking
• Ancillary/Diagnostic Testing
• Crusty, proliferative skin lesions – Infectious? 
• Skin Scraping 
• Chorioptes caprae
• Diagnosis of one patient problem
• Can’t stop here:
• Not all clinical signs fit
• Why did we find mites?
• Prevention
• Herd risks
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• Crusty, proliferative skin lesions – Infectious? 
• Biopsy – Dematophilus
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• Fecal floatation
• Why?
Bayesian Thinking
• Ancillary/Diagnostic Testing
• Weak/Depressed
• Recent travel, geographical change, and stress
• Pale mucous membranes
• PVC/TP – 8/6.5
• Chemistry Profile
• High Glucose
• Low Phosphorus
• High SDH 
• Fecal floatation
Bayesian Thinking
• Combination of information 
• Previous experience
• Pattern recognition 
• Physical exam findings
• Knowledge of prevalence of intestinal parasites, chorioptic mange and 
Dermatophilus in small ruminant populations (nationally  and regionally)
• Diagnostic testing information 
• Decreases uncertainty 
• Leads to confidence in treatment plan
Treatment
• Blood Transfusions
• Topical Ivermectin – whole barn 
• Discussed environmental biosecurity
• Repeated in 10 days
• Oral anthelmintic 
• Non-steroidal anti-inflammatory 
• Oxytetracycline
• Repeated in 14 days 
Testing Methods – How to select tests
• Depends on the diagnostic question
• What information is needed to minimize uncertainty  and allow 
action
• Anatomic, histologic, or clinical pathology correlated with certain disease 
processes or pathophysiology 
• Exposure or antibody response to pathogen
• Presence of pathogen
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Testing Methods – Diagnostic Question
• What information is needed for the next step?
• Histologic lesions
• Body system function  (dysfunction)
• Pathogen detection
• Pathogen  isolation
Testing Methods – Pathogen Detection
• Molecular Diagnostics
• PCR
• qPCR
• Very sensitive and specific
• Quick answer
• Recent MLV can be detected 
Testing Methods – Pathogen Isolation
• Virus Isolation
• Takes longer
• Dependent on viable virus in the sample
• Less sensitive than molecular methods
• Not all viruses can be isolated - BRSV
• Isolates can be sequenced
• BRD viral isolates can be from recent MLV
Testing Methods – Pathogen Isolation
• Bacterial Culture
• Takes longer
• Dependent on viable bacteria in the sample
• Affected by antibiotic administration 
• Antimicrobial susceptibility testing can be performed on 
isolates
How to select tests – Test Characteristics 
• Sensitivity – Probability of an animal being test positive given that 
it is truly disease positive
• Measure of the likelihood of a positive test in a diseased subject
• Freedom from false negatives
• Specificity – Probability of an animal being test negative given that 
it is truly free of disease 
• Measure of the likelihood of a negative test in a healthy subject 
• Freedom from false positives
Determined by comparing test results in a population to the results of a gold 
standard definitive diagnostic test
How to select tests – Test Characteristics 
• Sensitivity and specificity are population calculations
• Useful for comparing the performance of one test to another
• Stable to changes in prevalence
How to select tests – Test Characteristics 
• Positive predictive value - probability that the disease is present 
when the test is positive
• Higher value with high disease prevalence 
• Negative predictive value - probability that the disease is not 
present when the test is negative 
• Higher value with low disease prevalence 
• Both are population estimates that do not translate the 
interpretation of individual animal test results
• Disease prevalence estimates are not always available for external 
application to individual cases
Increase the likelihood of disease in a given subject before selecting the 
best test(s) for your goals 
How to select tests – Test Characteristics 
Individual Test Result 
• Sensitivity and Specificity
• “What is the percentage of diseased animals that are correctly classified 
by the test?” 
• What we need to know
• “What is the percent of test positive animals that are truly diseased?” 
How to select tests – Test Characteristics 
Individual Test Result 
• Likelihood Ratios 
• Quantitate the frequency of positive and negative test results in 
diseased and disease-free cases
• Do not depend on disease prevalence 
• Can be applied to cases regardless of population risks and 
characteristics
Likelihood Ratios 
• Used to assess the value of a diagnostic test 
• Positive LR (+LR) = Sensitivity / (1-Specificity)
• Negative LR (-LR) = (1- Sensitivity) / Specificity
• Translated into clinical practice via Bayes theorem
• Simplified by using probability revision graph or 
likelihood ratio normogram
By Mikael Häggström - Own work, CC0, https://commons.wikimedia.org/w/index.php?curid=17072735
Medical Uncertainty
• Test results do not agree with clinical suspicion
• Insufficient evidence to pinpoint pre-test probability Narrow 
range
• Lack of experience can lead to inaccurate pre-test probability 
• Likelihood normagrams developed to incorporate uncertainty into 
pretest probability estimates and final diagnostic interpretations
• visual tool - decide how much “weight” to give a diagnostic test result that 
contradicts with clinical suspicion
Test Sensitivity Specificity +LR -LR
Anaplasma marginale cELISA 1.00 1.00 333 0.00
BioPryn PSBP 0.99 0.95 19 0.01
Bovine Leukemia ELISA 0.98 0.99 98 0.02
BVD Ag ELISA ear 0.94 1.00 0 0.06
BVD Ag ELISA serum 0.97 1.00 0 0.03
H. somni qPCR 1.00 0.80 5 0.00
Johne's MAP ELISA 0.68 0.99 68 0.32
Johne's MAP qPCR 1.00 0.80 5 0.00
Leptospira spp. qPCR 0.90 0.95 18 0.11
M. bovis qPCR 0.90 0.92 11 0.11
M. haemolytica qPCR 1.00 0.56 2 0.00
P. multocida qPCR 1.00 0.66 3 0.00
T. pyogenes qPCR 0.89 0.93 13 0.12
Johne’s Disease (MAP) ELISA 
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Pre-test probability = 85%
+LR = 68
-LR = 0.32
Post-test probability = 99.7%
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Pre-test probability = 85%
+LR = 68
-LR = 0.32
Post-test probability = 64.5% 
Johne’s Disease (MAP) qPCR 
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Pre-test probability = 64.5%
+LR = 5
-LR = 0.001
Post-test probability = 0.2% 
Johne’s Disease (MAP) qPCR 
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Pre-test probability = 64.5%
+LR = 5
-LR = 0.001
Post-test probability = 90.1%
Improving Interpretation Potential
• True or False?
• A diagnostic test is more objective than a patient’s history and 
physical exam.
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•False
• A diagnostic test is more objective than a patient’s history and 
physical exam.
Improving Interpretation Potential
• Improve pre-test probability estimate as much as possible 
• Thorough history – patient, herd, management
• Knowledge of disease prevalence and risk of disease exposure 
(national or regional)
• Laboratory summaries or practice databases can potentially be developed
• Complete physical exam
• Diagnostic panels (test clusters) or clinical prediction guides 
Questions?
Feel free to contact me with any questions or 
feedback:
jessie.monday@tvmdl.tamu.edu
